Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

Personalize My Treatment (PMT) Registry

for
Cancer
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18+

Code: NCT02355171

Recruiting
New

A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)

for
Malignant Neoplam, Advanced Solid Tumors
Location: Belleville NJ, East Brunswick NJ, Toronto, Maumee OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07793942

Phase 2, Recruiting
New

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

for
Locally Advanced /Metastatic Solid Tumors,
Location: Orlando FL, Sarasota FL, Nashville TN, Dallas TX
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07857616

Phase 1, Recruiting
New

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07542704

Phase 1, Recruiting
New

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

for
Adenocarcinoma, Prostate Cancer, Neoplasms, Carcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18 - 70+

Code: NCT07574541

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer

for
Advanced Solid Tumour
Location: Sarasota FL, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07851103

Phase 1, Recruiting
New

A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment

for
Dysgeusia, Solid Tumor
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07419581

Recruiting
New

Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Counseling

for
Hereditary Breast Carcinoma, Hereditary Malignant Neoplasm
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT07887620

Recruiting
New

Facial Expression Awareness Training to Understand and Recognize Emotions

for
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 6 - 13

Code: NCT07923370

Recruiting
New

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07737314

Recruiting
New

SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET

for
Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer,
Location: Minneapolis MN
Sponsor: Full-Life Technologies UK Limited

Sex: All

Age: 18+

Code: NCT07873450

Phase 1, Phase 2, Recruiting
New

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

for
Advanced Solid Tumors, Recurrent or Progressive Glioblastoma,
Location: Fairfax VA, Tampa FL, Houston TX, Duarte CA
Sponsor: Crossbow Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07779798

Phase 1, Recruiting

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

for
Brain Metastases, Cancer (With CNS Involvement)
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07227610

Phase 2, Recruiting

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

for
Rectal Cancer Stage II, Rectal Cancer Stage III,
Location: Anchorage AK
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 21+

Code: NCT06802172

Recruiting

DOAC - Dosing Options in AntiCoagulation Prophylaxis

for
Cancer, VTE (Venous Thromboembolism)
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT07005024

Phase 3, Recruiting

Decoupling Immunotherapy Toxicity and Cancer Response

for
Tumor, Cardiovascular
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07382752

Recruiting

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

for
SMARCB1-Deficient Malignancies, Epithelioid Sarcoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT06444880

Phase 2, Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase 1, Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Durham NC,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06635785

Phase 1, Phase 2, Recruiting

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

for
Heart Failure, Cardiotoxicity, Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18 - 45

Code: NCT05023785

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial